دورية أكاديمية

A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis

التفاصيل البيبلوغرافية
العنوان: A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis
المؤلفون: Palmer, MelissaAff1, Jennings, LeeAff1, Silberg, Debra G.Aff2, Bliss, CalebAff1, Martin, PatrickAff1
المصدر: BMC Pharmacology and Toxicology: BMC series – open, inclusive and trusted. 19(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:20506511
DOI:10.1186/s40360-018-0200-y